About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
169
By Phase
PHASE2: 5PHASE3: 1
By Status
NOT_YET_RECRUITING: 3COMPLETED: 1UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06315608Lead Sponsor
MRG-001 in Patients With Amyotrophic Lateral Sclerosis
PHASE2Not yet recruiting
10 participants
Started: Jul 1, 2025 · Completed: Mar 1, 2026
NCT06308926Lead Sponsor
MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients
PHASE2Not yet recruiting
60 participants
Started: Dec 1, 2024 · Completed: Jul 1, 2026
NCT06307522Lead Sponsor
MRG-001 in Patients With Alcoholic Hepatitis
PHASE2Not yet recruiting
32 participants
Started: Sep 1, 2024 · Completed: Dec 1, 2026
NCT05844527Lead Sponsor
Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients
PHASE2Completed
10 participants
Started: Nov 20, 2023 · Completed: Sep 1, 2024
NCT04646603Lead Sponsor
MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients
PHASE2Unknown
40 participants
Started: Dec 1, 2021 · Completed: Jul 1, 2022
Locations (1)
Headquarters
Baltimore, MD, United States
Map
Loading map...